Virginia House And Senate Lawmakers Advance Marijuana Sales Legalization Bills Toward Governor’s Desk
Trump’s Cannabis Rescheduling Move Alone Won’t Stabilize The Industry Without Insurance Reimbursement Reform (Op-Ed)
Connecticut Lawmakers Approve Bill To Expand Psychedelics Pilot Program In Anticipation Of FDA Approval
Wisconsin Governor Pushes To Stop Federal Hemp THC Ban, Saying Lack Of Legal Marijuana In State Makes The Impacts ‘Intensified’
Washington Senators Approve Bill To Let Terminally Ill Patients Use Medical Cannabis In Hospitals
Scientists Reveal What Types Of Food The Marijuana ‘Munchies’ Make You Crave The Most
AI Models Like ChatGPT Can Generate ‘Convincingly Realistic’ Psychedelic Experiences When Virtually Dosed, Study Shows
Cannabis-Infused Drinks Offer Consumers A ‘Harm Reduction’ Alternative To Alcohol, Study Shows
Marijuana Use Isn’t A ‘Red Flag’ In The Dating Scene, Three In Four Americans Say In New Survey
10 Million US Adults Microdosed Psychedelics Last Year, New Report Shows
DEA Promotes Anti-Marijuana PSA Contest Inviting Students To Warn Peers About THC Dangers On 4/20
Largest Entertainment Arena In US Partners With Cannabis Businesses To Sell THC Drinks At Concerts And Live Events
Woody Harrelson Got Kicked Out Of Two Bars For Smoking Marijuana With Matthew McConaughey’s Mom
State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays
One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds
Marijuana Kiosks For Seniors Are Coming To Independent Living Communities Across Arizona
Montana Retailers Have Sold More Than $1 Billion Worth Of Recreational Marijuana Since Legalization Took Effect
Pre-Rolls Are A Key Driver Of The Cannabis Retail Market’s Success (Op-Ed)
Massachusetts Hits $10 Billion Marijuana Sales Milestone, With Top Official Saying Consumption Lounges Will Bolster Industry In 2026
Ohio Dispensaries Sold More Than $1 Billion Worth Of Legal Marijuana In 2025
Supreme Court talks cannabis rescheduling in gun rights hearing (Newsletter: March 3, 2026)
Bills on cannabis use in hospitals advance in several states (Newsletter: March 2, 2026)
Hemp THC ban delay hits roadblock in Congress (Newsletter: February 27, 2026)
ACLU previews cannabis & guns arguments for Supreme Court (Newsletter: February 26, 2026)
Congress will consider hemp THC product ban delay next week (Newsletter: February 25, 2026)
Published
on
By
South Dakota lawmakers have rejected a pair of bills that would have ended the state’s medical marijuana program if the plant is federally rescheduled and to set strict THC potency caps on cannabis products for patients.
The Senate Health and Human Services Committee on Wednesday took up both measures from Sen. John Carley (R), rejecting the medical marijuana repeal bill in a 7-0 vote and the potency proposal in a 6-1 vote.
Under the first bill, South Dakota’s voter-approved medical cannabis program would have been eliminated 90 days after the federal government finalized the rescheduling of marijuana under the Controlled Substance Act (CSA)—a policy change that’s actively in the works, as President Donald Trump in December ordered that process to be expeditiously completed.
“Rescheduling cannabis from Schedule l to Schedule lll does not make medical cannabis accessible nationwide,” the Marijuana Policy Project (MPP) said in an action alert ahead of the vote. “It is cruel and cynical to marry the two issues and eliminate a program 70 percent of voters enacted, just as federal law recognizes the efficacy of medical cannabis.”
“If SB 181 passed, South Dakota’s medical cannabis program would strip legal protections and safe access from 18,000 patients,” it said. “Forty states have medical programs. None have repealed their state’s medical cannabis programs.”
In testimony to the committee, the state Department of Health voiced opposition to the legislation.
Carley’s other bill would have made it so medical cannabis products available to patients couldn’t exceed 5 percent THC for oils or 60 percent for liquid concentrates. The Senate panel also soundly defeated that proposal.
“The THC potency cap is not based on scientific research for what is best for medical patients,” MPP said. “This would deprive patients of the products that work best for them.”
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
These votes come weeks after senators separately voted not to take up a measure to ban intoxicating hemp cannabinoid products.
Also last month, the House Health and Human Services Committee rejected a bill that would have allowed terminally ill patients to use medical cannabis in hospitals and hospices.
Around this time last year, Rep. Travis Ismay (R) attempted to repeal the state’s medical marijuana program, but his proposal was also defeated in committee.
Photo courtesy of Philip Steffan.
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. He’s covered drug policy for more than a decade—specializing in state and federal marijuana and psychedelics issues at publications that also include High Times, VICE and attn. In 2022, Jaeger was named Benzinga’s Cannabis Policy Reporter of the Year.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell